Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03602612
What this trial is testing

T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma

Who this might be right for
Myeloma-MultipleMyeloma, Plasma-Cell
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT05639972
What this trial is testing

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Who this might be right for
HPV-Associated Cervical CarcinomaHPV-Related CarcinomaHPV-Related Malignancy+14 more
Christian Hinrichs 15
Testing effectiveness (Phase 2)Study completedNCT00003553
What this trial is testing

Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Heart, Lung, and Blood Institute (NHLBI) 156
Testing effectiveness (Phase 2)Looking for participantsNCT05634369
What this trial is testing

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

Who this might be right for
Pediatric Sarcoma, RefractoryPediatric Sarcoma, Relapsed
Nationwide Children's Hospital 50
Early research (Phase 1)Study completedNCT00107354
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT06358053
What this trial is testing

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Who this might be right for
Cervical CancerAnal CancerHead and Neck Cancers+1 more
Corregene Biotechnology Co., Ltd 24
Testing effectiveness (Phase 2)Looking for participantsNCT05361174
What this trial is testing

Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Who this might be right for
Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more
Iovance Biotherapeutics, Inc. 53
Large-scale testing (Phase 3)Study completedNCT01077908
What this trial is testing

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 89
Testing effectiveness (Phase 2)Ended earlyNCT02111863
What this trial is testing

Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT00001647
What this trial is testing

White Blood Cell Infusions to Treat HIV Infection

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT03958656
What this trial is testing

T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma

Who this might be right for
Myeloma-MultipleMyeloma, Plasma-Cell
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00027573
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)Looking for participantsNCT03412877
What this trial is testing

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Who this might be right for
Endocrine TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
National Cancer Institute (NCI) 285
Early research (Phase 1)Study completedNCT03338972
What this trial is testing

Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT04422912
What this trial is testing

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Who this might be right for
Pemphigus Vulgaris
Cabaletta Bio 40
Early research (Phase 1)Ended earlyNCT04735471
What this trial is testing

ADI-001 in B Cell Malignancies

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 34
Testing effectiveness (Phase 2)Ended earlyNCT01995344
What this trial is testing

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Who this might be right for
Metastatic Melanoma
The Christie NHS Foundation Trust 2
Testing effectiveness (Phase 2)Study completedNCT00058656
What this trial is testing

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Who this might be right for
Chronic Lymphocytic Leukemia
Xcyte Therapies 18
Testing effectiveness (Phase 2)Study completedNCT02593123
What this trial is testing

Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis

Who this might be right for
Hodgkin's LymphomaLymphoid LeukemiaLymphoma+15 more
Virginia Commonwealth University 31
Early research (Phase 1)Study completedNCT02096614
What this trial is testing

Investigator Initiated Phase 1 Study of TBI-1201

Who this might be right for
Solid Tumors
Mie University 18
Next Page